Study Finds It's Safe To Treat HER2-Positive Breast Cancer With Trastuzumab And Adjuvant Radiation

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)--typically used in combination with chemotherapy.